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ABSTRACT
The Chinese herbal medicine, Xiao-Chai-Hu-Tang (XCHT), with Bupleurum radix as the main ingredient, is used for treating
hepatitis. Although there are many varieties of Bupleurum in the herbal market, Bupleurum kaoi is the only indigenous species
belonging to the Bupleurum genus plant in Taiwan which is commercially cultivated for making health-promoting products. The
present study examined the hepatoprotective and antioxidative properties of XCHT formulated with commercially cultivated B.
kaoi. The activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), superoxide dismutase (SOD), catalase,
glutathione peroxidase (GPx), glutathione reductase (GRd) and glutathione-S-transferase (GST) as well as lipid peroxidation in rats
treated with CCl4 were analyzed to evaluate the hepatoprotective property of XCHT. The results showed that the enzyme levels in
the serum of rats treated with XCHT extract prior to receiving CCl4 were significantly lower (p < 0.05) than those in the rats that
received CCl4 only. Malondialdehyde formation was also reduced when XCHT extract was given. In comparison with the extract
of XCHT, the extract of B. kaoi showed similar hepatoprotective abilities. Since the levels of SOD, catalase, GPx, GRd and GST
were compensation increased in CCl4 treatment, it was suggested that XCHT or B. kaoi markedly suppressed lipid peroxidation and
reversed the activities of the antioxidant enzymes to the normal levels.
Key words: Bupleurum kaoi Liu, carbon tetrachloride, Xiao-Chai-Hu-Tang, antioxidative enzymes, hepatoprotective functionality

INTRODUCTION
Xiao-Chai-Hu-Tang (XCHT) is a traditional Chinese
herbal medicine which is used mainly for treating
chronic hepatitis, and also for distress and fullness in the
chest and ribs in China and Japan(1). Although XCHT is
composed of seven medicinal herbs, it is generally recognized that Bupleurum radix contributes the major protective functionality because it is the principal component
of XCHT(2). While many varieties of Bupleurum species
(belonging to the family Umbelliferae) are available
in the herbal market, Bupleurum kaoi Liu (Chao et
Chuang) is the only indigenous Bupleurum plant in
Taiwan. It is reported that B. kaoi Liu possesses free
* Author for correspondence. Tel: +886-4-9311498 ext. 1108;
Fax: +886-4-8395316; E-mail: cytseng@dragon.ccut.edu.tw

radical scavenging activities and inhibits the formation
of superoxide radicals (3-5). To broaden the utilization of
traditional herbal prescriptions, XCHT has been targeted
for commercial production as health food and large-scale
cultivation of B. kaoi is performed to meet the raw material requirement. Wu et al. demonstrated that XCHT that
contained B. kaoi exhibited the same levels of DPPH
radical scavenging effect, reducing power, and total antioxidant capacity as XCHT that contained B. Chinense (6).
Although the water extracts of B. kaoi roots alone had
been shown to protect the liver against carbon tetrachloride (CCl4)-, D-galactosamine- or dimethylnitrosamine-induced hepatotoxicity(7-9), the hepatoprotective
functionality of XCHT formulated with commercially
cultivated B. kaoi needs to be verified.
As the mechanism of CCl4 -induced hepatic necrosis
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has been well-documented, CCl4 is widely used to investigate hepatotoxic effects in various animal studies(10,11).
Superoxides and hydroxyl radicals derived from CCl4 are
the principal toxic substances interacting with the liver
tissue. Detoxifying reactions catalyzed by superoxide
dismutase (SOD), catalase, glutathione peroxidase (GPx),
glutathione reductase (GRd), and glutathione-S-transferase
(GST) transform toxic free radicals to less toxic or nontoxic species and serve as defense mechanisms against
CCl4 in biological systems. SOD and catalase inactivate
free radical precursors and prevent the formation of active
oxygen species(12). While GPx decomposes hydrogen
peroxide and other peroxides, GRd serves as a reductase of
GSSG (oxidized glutathione). In addition to the protective
role of the enzymes described above, compounds such as
vitamin E and glutathione that are known for their antioxidant properties, and other compounds that act as inhibitors
of cytochrome P-450 have also been reported to reduce the
extent of peroxidation and decrease the toxicity induced by
CCl4 in animal models(13). In this study, CCl4 was used as
a liver damage-inducing agent and the activities of protective enzymes were analyzed to demonstrate the hepatoprotective properties of XCHT formulated with commercially
cultivated B. kaoi.

MATERIALS AND METHODS
I. Chemicals
Baicalin, baicalein, glycyrrhizic acid, saikosaponin
a, saikosaponin c and saikosaponin d were purchased from
Wako Pure Chemical Industries Ltd. (Osaka, Japan). FolinCiocalteu’s reagent, gallic acid, potassium chloride (KCl),
disodium hydrogen phosphate (Na2HPO4), sodium dihydrogen phosphate (NaH2PO4), quercetin, sodium carbonate
(Na2CO3), sodium dodecylsulphate (SDS), 1,1,3,3-tetraethoxy propane (TEP) and Triton X-100 were purchased from
Sigma Chemical Co. (St Louis, MO). Acetonitrile, ethanol,
hydrochloric acid (HCl) and methanol were purchased
from Merck Co. (Darmstadt, Germany). Aluminum nitrate
(Al(NO3)3), formaldehyde solution (CH2O) and potassium acetate (CH3COOK) were purchased from J. T.
Baker Co. (Phillipsburg, NJ). Hydrogen peroxide (H2O2)
was purchased from Sigma-Aldrich Inc. (St Louis, MO).
Tris(hydroxymethyl) aminomethane hydrochloride (TrisHCl) and thiobarbituric acid (TBA) were purchased from
Acros Chemical (Morris Plains, NJ). N-butanol was
purchased from Fisher Co. (Fair Lawn, NJ). Carbon tetrachloride (CCl4) was obtained from Hayashi Pure Chemical
Ind. (Osaka, Japan). Silymarin was obtained from Tecmed
Medico GmbH (Hamburg, Germany).
II. Preparation of B. kaoi and Xiao-Chai-Hu-Tang (XCHT)
Extracts
Dried roots of 8 month-old B. kaoi were obtained

from the plantation of the Green Health Biotechnology
Corporation (Yunlin, Taiwan). The roots were ground
with a blender, mixed with 10 volumes of distilled water
(w/v), and boiled under reflux for 2 h. The aqueous
extract was filtered through a Whatman filter paper (No.
1) and the filtrate was freeze-dried (The 12ES, Freeze
Dryer, Virtes Company, Inc., Gardiner, NY) into dry
powder for further analysis. The yield of freeze-dried
Bupleurum kaoi powder was 17.1%.
The tuber of Pinellia ternate (Pinelliae tuber), fruits
of Zizyphus jujube (Zizyphi fructus), rhizome of Zingiber
officinale (Zingiberis rhizome) and roots of Panax
ginseng (Ginseng radix), Scutellaria baicalensis (Scutellariae radix) and Glycyrrhiza uralensis (Glycyrrhizae
radix) were purchased from a local herb pharmacy and
authenticated. The formulation of XCHT was prepared
according to Sakaguchi et al.(2) and the ratio (by weight)
of Bupleurum kaoi, Pinelliae tuber, Ginseng radix, Zizyphi
fructus, Scutellariae radix, Glycyrrhizae radix and Zingiberis rhizome was 7: 5: 3: 3: 3: 2: 1. The herbal ingredients were pooled together and ground with a blender.
The pulverized herbs were mixed with 10 volumes of
distilled water (w/v) and then boiled under reflux for 2 h.
The freeze-dried powder of XCHT was prepared in the
same way as B. kaoi powder described above. The yield of
freeze-dried XCHT powder was 22.0%.
III. Determination of Flavonoids and Total Phenols
Freeze-dried B. kaoi or XCHT powder was dissolved
in distilled water and the flavonoid concentration
was determined using the method described by Jia et
al.(14). The sample solution (0.5 mL), ethanol (1.5 mL),
Al(NO3)3 (0.1 mL, 10%), CH 3COOK (0.1 mL, 1 M) and
H 2O (2.8 mL) were thoroughly mixed and kept at room
temperature for 40 min. The absorbance of the reaction
mixture at 415 nm was measured with a spectrophotometer (U-2000 Spectrophotometer, Hitachi Ltd., Tokyo,
Japan). The flavonoid content was calculated according to
a standard curve established with quercetin. The content
of total phenols was determined using Folin-Ciocalteu’s
reagent as described by Taga et al.(15). The sample solution (0.1 mL), Folin-Ciocalteu’s reagent (0.5 mL), sodium
carbonate (0.4 mL, 7.5%) and distilled H 2O (5 mL) were
thoroughly mixed and kept at room temperature for
30 min before its absorbance at 760 nm was measured.
The content of total phenols was calculated according to
a standard curve established with gallic acid.
IV. Saikosaponins, Baicalin, Baicalein and Glycyrrhizic
Acid Analyses
The freeze-dried B. kaoi or XCHT powder was
dissolved in distilled water and the concentrations of
saikosaponins (saikosaponin a, c and d) were analyzed
with a high performance liquid chromatograph (HPLC
L-7000, Hitachi Ltd., Tokyo, Japan) equipped with an
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Inertsil ODS-3 C18 column (250 × 4.6 mm, GL Sciences,
Tokyo, Japan). A programmed gradient elution using
acetonitrile-water from 40 : 60 (v/v) to 50 : 50 (v/v) in 10
min at a flow rate of 1.0 mL/min and detection wavelength
of 203 nm was used(16). In the analysis of baicalin, baicalein and glycyrrhizic acid, the mobile phase consisted
of (A) 25 mM NaH 2PO4 (pH 2.5) and (B) acetonitrile.
The eluent composition was initially set at 30% of B,
increased to 100% B in 25 min, and then held for 10 min
before returning to the initial composition. The detection
wavelength was 277 nm for baicalin, 280 nm for baicalein
and 252 nm for glycyrrhizic acid. Standard curves established with saikosaponins a, c and d, baicalin, baicalein,
and glycyrrhizic acid were used for the calculation.
V. Animal Treatment
Eight-week old male Sprague-Dawley rats, weighing
280-310 g, were purchased from the National Laboratory Animal Center (Taipei City, Taiwan). They were
processed according to the suggested international ethical
guidelines for the care of laboratory animals. The experimental protocol was approved by the Laboratory Animal
Management Committee of National Chiayi University
(Chiayi, Taiwan). The animals were housed individually
and maintained under standard laboratory conditions of
a 12-h light/dark cycle and fixed temperature (25 ± 2°C).
The rats were provided with tap water and chow diets
(Lab Diet; PMI Nutrition International Inc., Brentwood,
MO) ad libitum during the entire duration of the experiment. The rats were randomly assigned into seven groups,
with six animals in each group. For four of the groups,
freeze-dried powder of B. kaoi or XCHT dissolved in
distilled water was given at the level of 100 or 500 mg/kg
body weight (bw) daily by gavage to the animals on three
consecutive days. Immediately after the third gavage,
CCl4 (CCl4 : olive oil = 1 : 1, 3 mL/kg bw) was injected
(Intraperitoneal injection, i.p.) into the animals to induce
acute liver damage. The rats were anesthetized with ethyl
ether and scarified 24 h after CCl4 injection. The experiment procedures in the control groups (normal control,
CCl4 -treated, and silymarin group) were the same as in
the experiment groups, except for the following: Rats
in the normal control group were given distilled water
to replace the herbal extracts and injected with olive
oil without CCl4 (3 mL/kg bw, i.p.). rats in CCl4 -treated
group were given distilled water to replace the herbal
extracts and injected with CCl4, while the rats in the
silymarin control group did not receive herbal extract or
distilled water but were given silymarin (25 mg/kg bw) by
gavage before CCl4 injection. Silymarin was used a medicine that protects the liver against CCl4(11,17).
VI. Analysis of Serum Transaminases and Cholesterol
Blood was collected through the hepatic vein of
animals 24 h after treatment with CCl4 or olive oil. After

centrifuging the blood at 3000 ×g and 4°C for 10 min,
serum aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) activities were determined as
the biochemical markers for hepatic cellular damage
using commercial kits (Raichem, Division of Hemagen
Diagnostics, Inc., San Diego, CA). They were analyzed
by spectroscopy (Chiron/Diagnostics Express Plus, East
Walpole, MA) and the results were expressed in U/L. The
levels of serum cholesterol were assayed with a commercial kit (Raichem, Division of Hemagen Diagnostics, Inc.,
San Diego, CA) and the results were expressed in mg/dL.
VII. Analysis of Rat Liver Lipid Peroxidation
Lipid peroxidation of the liver homogenate was
measured according to the method of Sano et al.(18) and
Fraga et al.(19). Immediately after the animals were sacrificed, their livers were removed, weighed and rinsed with
ice-cold 0.1 M Tris-HCl buffer. The liver samples were
homogenized in ice-cold buffer (8 mM Na 2HPO4, 12 mM
NaH 2PO4, 1.5% KCl, pH 7.4) in a homogenizer (Glas-Col,
Terre Haute, IN) to make a 10% (w/v) liver homogenate.
The protein content was determined with the method by
Lowry et al.(20) using a commercial kit (Randox Laboratories Ltd., Crumlin, Co. Antrim, UK). After centrifuging
at 105,000 ×g, 4°C for 20 min (CF15D2, Hitachi Ltd.,
Tokyo, Japan), lipid peroxidation was determined with the
thiobarbituric acid fluorometric method with emission at
553 nm and excitation at 515 nm using TEP as the standard(21,22). The results were expressed as MDA nmol/mg.
VIII. Activities of Rat Liver Antioxidant Enzymes
Liver homogenate was used for the assay of antioxidant enzyme activities. The activity of SOD in the liver
was evaluated using commercial kits (Randox Laboratories Ltd., Crumlin, Co. Antrim, UK). The specific
enzyme activity of SOD was expressed as U/mg protein.
Catalase activity in the liver was measured using the
method described by Aebi(23). The reaction mixture (2
mL), which consisted of 10 μL of liver homogenate, 90
μL of 1% Triton X-100 and 1.9 mL of 20 mM of phosphate buffer, was added to a photometric quartz cuvette
containing 1 mL of H 2O2 (0.03 M). The initial absorbance (A1) and final absorbance (A2) of a 1-min time
interval at 240 nm were measured and used to calculate
the reaction rate constant (K) using the equation K =
(2.3/∆t) × log(A1/A2). The specific activity of the enzyme
was expressed as K/mg protein.
IX. Determination of Rat Liver Glutathione Metabolic
Enzyme Activities
The glutathione peroxidase (GPx) and glutathione
reductase (GRd) activities of rat liver were spectroscopically
analyzed using commercial kits (Randox Laboratories
Ltd., Crumlin, Co. Antrim, UK) and a spectrophotometer
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Table 1. The contents of total phenols, flavonoids, saikosaponins, baicalin, baicalein and glycyrrhizic acid in the extracts of B. kaoi and
Xiao-Chai-Hu-Tang (XCHT)
Sample

Compounds1 (mg/g dry weight)
Total phenols2

Flavonoids3

Saikosaponins

Baicalin

Baicalein

Glycyrrhizic acid

B. kaoi

13.5 ± 0.7

4.0 ± 0.1

1.0 ± 0.0

ND4

ND

ND

XCHT

12.0 ± 0.4

3.6 ± 0.1

0.9 ± 0.1

0.6 ± 0.1

0.4 ± 0.0

0.3 ± 0.0

1

Each value represents means ± SD (n = 3).
The content of total phenols was calculated against gallic acid standard.
3
The content of flavonoids was calculated against quercetin standard.
4
ND = Not detected.
2

as specified. The GPx and GRd activities were expressed
as U/mg protein. Hepatic glutathione-S-transferase (GST)
activity was analyzed according to the method described
by Habig et al(24). Liver homogenate (5 μL) was added
with phosphate buffer solution (95 μL, pH 7.0, 20 mM),
GSH (1 mM in 100 mM phosphate buffer), and 1-chloro2,4-dinitrobenzene (CDNB) (20 μL, 50 mM). The CDNBGSH conjugate formed in 5 min was measured at 340 nm
with a spectrophotometer (U-2000, Hitachi Ltd., Tokyo,
Japan). The GST activity was expressed as nM CDNBGSH conjugate/min/mg protein. For the determination of
blank samples, liver homogenate was replaced with the
same buffer of the homogenate.
X. Histopathological Examination
Liver tissues of rats were collected from the central
lobe of the liver for comparison purpose. The liver tissue
was fixed in 10% neutral formalin, dehydrated with
a graded series of ethanol solutions and embedded in
paraffin. Thin sections of liver tissues were stained with
haematoxylin and eosin (H&E) for microscopic examination. Histopathological examination was performed by
Professor Ming-Huang Chang (Department of Veterinary
Medicine, National Chiayi University, Chiayi, Taiwan).

Table 2. The effects of B. kaoi and XCHT extracts on the serum
transaminase activities of Sprague-Dawley rats treated with CCl4
Animal treatment group1
Normal control
CCl4
Silymarin (25) + CCl4

Serum Transaminases (U/L)2
AST

ALT

293 ± 70d

82 ± 21e

2058 ± 443a

1249 ± 218a

651 ± 434cd

205 ± 185de

B. kaoi (100) + CCl4

1948 ± 177a

1016 ± 160b

B. kaoi (500) + CCl4

1038 ± 492bc

418 ± 219c

XCHT (100) + CCl4

483 ± 373d

360 ± 160cd

XCHT (500) + CCl4

1213 ± 403b

428 ± 162c

1

Normal control: The rats were given distilled water and injected
with olive oil; CCl 4: The rats were given distilled water and
injected with CCl4; Silymarin (25) + CCl4: The rats were given
silymarin (25 mg/kg bw) before CCl4 injection; B. kaoi (100) +
CCl4: The rats were given B. kaoi extract (100 mg/kg bw) before
CCl4 injection; B. kaoi (500) + CCl4: The rats were given B. kaoi
extract (500 mg/kg bw) before CCl4 injection; XCHT (100) + CCl4:
The rats were given XCHT extract (100 mg/kg bw) before CCl4
injection; XCHT (500) + CCl4: The rats were given XCHT extract
(500 mg/kg bw) before CCl4 injection.
2
Each value represents means ± SD (n = 6). Means with different
letters within the same column are significantly different (p < 0.05).

XI. Statistical Analyses
Data were presented as means ± SD. One-way analysis of variance was used to analyze the variance among
the samples. Duncan’s multiple range tests, at p < 0.05,
was used to determine significant differences among
sample means.

RESULTS
I. Bioactive Compounds in B. Kaoi and XCHT
The contents of total phenols, flavonoids, saikosaponons, baicalin, baicalein and glycyrrhizic acid in
the extracts of B. kaoi and XCHT are listed in Table 1.
No significant differences ( p > 0.05) in the contents of

total phenols, flavonoids and saikosaponins were found
between B. kaoi and XCHT. However, baicalin, baicalein, and glycyrrhizic acid were detected only in XCHT
because baicalin and baicalein are found in Scutellariae
radix only and glycyrrhizic acid is a specific compound
found in Glycyrrhizae radix.
II. Effects of B. Kaoi and XCHT on AST and ALT Activities
The levels of serum transaminase activities in the
rats subjected to different treatment are shown in Table
2. AST and ALT of the CCl4 -treated group were significantly higher than the normal control group. B. kaoi
extract at a dose of 500 mg/kg bw and XCHT extract at
a dose of 100 or 500 mg/kg bw significantly lowered the
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AST and ALT activities when compared with the rats in
the CCl4 -treated group.
III. Effects of B. Kaoi and XCHT on Serum Cholesterol and
Lipid Peroxidation
Serum cholesterol level can be used as a diagnostic indicator for artherosclosis, high blood pressure,
malabsorption, fatty liver and anemia (25). Although the
administration of CCl4 slightly increased serum cholesterol level (Table 3), it is interesting to note that the
serum cholesterol levels of animals treated with extracts
of B. kaoi or XCHT were lower than those found in the
animals of the normal control group. The formation of
MDA was used to represent the peroxidation of liver

Table 3. The effects of B. kaoi and XCHT extracts on the serum
cholesterol and hepatic malondialdehyde (MDA) concentrations of
Sprague-Dawley rats treated with CCl4
Animal treatment group1

1
2

Cholesterol
2

MDA

mg/dL

nmol/mg protein2

Normal control

55 ± 7a

1 ± 0d

CCl4

57 ± 10a

13 ± 4b

Silymarin (25) + CCl4

56 ± 15a

16 ± 4a

B. kaoi (100) + CCl4

47 ± 9ab

18 ± 3a

B. kaoi (500) + CCl4

42 ± 14b

4 ± 1cd

XCHT (100) + CCl4

50 ± 8ab

4 ± 0c

XCHT (500) + CCl4

42 ± 8b

2 ± 0cd

Animal treatment is the same as in Table 2.
 ach value represents means ± SD (n = 6). Means with different
E
letters within the same column are significantly different (p < 0.05).

Table 4. The effects of B. kaoi and XCHT extracts on the liver
superoxide dismutase (SOD) and catalase activities of SpragueDawley rats treated with CCl4

2

IV. Effects of B. Kaoi and XCHT on SOD and Catalase
Activities
The SOD and catalase activities of the rat liver
homogenates are listed in Table 4. Acute liver damage
resulting from CCl4 administration was indicated by an
increase in the activities of these two enzymes. Although
silymarin reduced the activities of both enzymes, the
extracts of B. kaoi and XCHT exerted even stronger
protective effects in the case of SOD and catalase.
V. Effects B. Kaoi and XCHT on Glutathione Metabolic
Enzymes
The activities of hepatic enzymes involving glutathione metabolism are listed in Table 5. Compensative
increases of hepatic GPx, GRd and GST were observed
after CCl4 was injected into the rats. The extracts of B.
kaoi and XCHT exerted similar protective effects when
compared to silymarin. No significant differences in the
activities of GPx, GRd and GST were found between
animals given the extracts of B. kaoi and XCHT extracts
and animals in the normal control group.
VI. Pathologic Changes in Rat Liver
Microscopic observation of histological samples
Table 5. The effects of B. kaoi and XCHT extracts on the liver
glutathione metabolic enzymes activities of Sprague-Dawley rats
treated with CCl4

Animal treatment
group1

GPx

GRd

GST

mU/mg
protein2

mU/mg
protein2

nM
CDNB-GSH
conjugate/min/
mg protein2

SOD

Catalase

mU/mg protein2

mK/mg protein2

Normal control

151 ± 18c

169 ± 55b

Normal control

149 ± 13bc

595 ± 50b

10 ± 1c

CCl4

254 ± 49a

246 ± 35a

CCl4

263 ± 20a

1051 ± 79a

19 ± 6a

Silymarin (25) + CCl4

198 ± 24b

140 ± 30bc

Silymarin (25) + CCl4

150 ± 25bc

601 ± 100b

9 ± 8c

B. kaoi (100) + CCl4

190 ± 13b

131 ± 20c

B. kaoi (100) + CCl4

162 ± 16b

669 ± 99b

17 ± 5ab

B. kaoi (500) + CCl4

171 ± 30bc

106 ± 12c

B. kaoi (500) + CCl4

162 ± 34b

648 ± 137b

11 ± 5bc

XCHT (100) + CCl4

166 ± 19bc

124 ± 13c

XCHT (100) + CCl4

164 ± 15b

655 ± 61b

9 ± 2c

XCHT (500) + CCl4

141 ± 8c

102 ± 10c

XCHT (500) + CCl4

131 ± 15c

556 ± 61b

12 ± 6bc

Animal treatment group1

1

tissue (Table 3). In comparison with the normal control
group, animals treated with CCl4 showed a 12-fold
increase in MDA level. Furthermore, the extract of B.
kaoi (500 mg/kg bw) and the extract of XCHT (100 and
500 mg/kg bw) significantly reduced lipid peroxidation
when compared with the CCl4 -treated animals.

Animal treatment is the same as in Table 2.
Each value represents means ± SD (n = 6). Means with different
letters within the same column are significantly different (p < 0.05).

1
2

Animal treatment is the same as in Table 2.
Each value represents means ± SD (n = 6). Means with different
letters within the same column are significantly different (p < 0.05).
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can provide direct evidence for pathogenic changes in
animals. Typical histological samples of the liver tissue
from the different treatment animal groups are shown in
Figure 1. Hepatocyte inflammation, hepatocyte necrosis,
fatty change, balloon degeneration and bile duct proliferation were scored and reported in Table 6. While hepatocyte inflammation was observed only in rats in the CCl4
group, hepatocyte necrosis was observed in all the rats
except the rats in the normal control group. The B. kaoi
and XCHT extracts had little effect on fatty change of
the liver. However, silymarin and extracts of B. kaoi and
XCHT reduced the liver balloon degeneration induced by
CCl4. In the overall histological observation, B. kaoi and
XCHT extracts demonstrated similar hepatoprotective
effects as silymarin.

DISCUSSION
Herbs have been used in folk medicine around the
world for thousands of years with little or no knowledge
of their active components or modes of action. The isolation and purification of phytochemicals from some herbs
and subsequent pharmacological studies have revealed

a few of the long-sought mysteries of herbal medicine
and their healing capabilities. In traditional Chinese
philosophy, food and medicine are derived from the same
origin and both serve to enhance human health. Although
herbal medicine is traditionally used to treat diseases,
herbal ingredients are currently being formulated into
health food and drinks and play an important role in the
prevention of diseases. The results of this study demonstrated that the administration of B. kaoi and XCHT
formulated with commercially cultivated B. kaoi can
reduce hepatic damage caused by CCl4 in rats.
AST and ALT are two enzymes found in normal liver
cells. When severe liver damage occurs, these enzymes
are released into the blood stream. Increases of serum
AST and ALT levels resulting from massive liver cell
damage can be observed in acute hepatitis induced by
CCl4 in laboratory animals(26). Central lobular necrosis,
balloon degeneration and cellular infiltration were
detected in intoxicated rat tissue samples. Ingestion of B.
kaoi extract (500 mg/kg bw) and XCHT extract (100 and
500 mg/kg bw) prior to the administration of CCl4 significantly decreased the AST and ALT levels in the serum.
Reduced liver damage and lesser enzyme penetration
through the cell membrane might be used to explain the

Figure 1. Effects of B. kaoi and Xiao-Chai-Hu-Tang (XCHT) on CCl4 -induced liver damage of
Sprague-Dawley rats (400×). (A) Normal control: The rats were given distilled water to replace
herbal extract and injected with olive oil without CCl4; (B) CCl4: The rats were given distilled
water to replace herbal extract and injected with CCl4; (C) Silymarin (25) + CCl4: The rats
were given distilled water to replace herbal extract and given silymarin (25 mg/kg bw) before
CCl4 injection; (D) B. kaoi (100) + CCl4: The rats were given B. kaoi extract (100 mg/kg bw)
for 3 consecutive days before CCl4 injection; (E) B. kaoi (500) + CCl4: The rats were given B.
kaoi extract (500 mg/kg bw) for 3 consecutive days before CCl4 injection; (F) XCHT (100) +
CCl4: The rats were given XCHT extract (100 mg/kg bw) for 3 consecutive days before CCl4
injection; (G) XCHT (500) + CCl4: The rats were given XCHT extract (500 mg/kg bw) for 3
consecutive days before CCl4 injection.
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Table 6. Pathologic changes in the liver of Sprague-Dawley rat treated with B. kaoi or XCHT extracts and exposed to CCl4 -induced acute
hepatic damage
Injury Score
Animal treatment groupa

Inflammationb

Hepatocytec necrosis

Fatty changed

Balloone
degeneration

Bile ductf
proliferation

Normal control

0

0

0

0

0

CCl4

1

1

2

2

0

Silymarin (25) + CCl4

0

1

2

1

0

B. kaoi (100) + CCl4

0

1

2

1

0

B. kaoi (500) + CCl4

0

1

2

1

0

XCHT (100) + CCl4

0

1

2

1

0

XCHT (500) + CCl4

0

1

2

1

0

a

Animal treatment is the same as in Table 2. The results are derived from the overall observation of the six animals in the group.
Score 0 = no significant lesion; score 1 = mild inflammation; score 2 = limited in portal area; score 3 = piecemeal necrosis aggregation in
parenchyma; score 4 = marked inflammation.
c
Score 0 = no significant lesion; score 1 = spotty necrosis; score 2 = a lot of spotty necrosis; score 3 = confluent necrosis; score 4 = massive
necrosis.
d
Score 0 = no significant lesion; score 1 = micro fatty change; score 2 = sporadic or diffuse micro fatty change; score 3 = massive fatty
change; score 4 = marked diffuse.
e
Score 0 = no significant lesion; score 1 = slight; score 2 = mild; 3 = moderate; 4 = severe.
f
Score 0 = no significant lesion; score 1 = 2-3 bile ducts in a big portal; score 2 = 2-3 bile ducts in each portal area; score 3 = over 3-5 bile
ducts in each portal area; score 4 = adenoma.
b

hepatoprotective activity.
CCl4 is a typical hepato-toxic chemical used in
animal studies(11). CCl4 is converted to the trichloromethyl
free radical (CCl3˙) and then to the trichloromethylperoxyl radical (CCl3O2˙) in sequence by the cytochrome
P-450 system. The resulting CCl3O2˙ catalyzes lipid
peroxidation, interferes with calcium homeostasis and
causes cell death(27,28). Reduction of the formation of
CCl3˙ and CCl3O2˙ free radicals can inhibit lipid peroxidation and subsequent cell damage. As our study showed
that both B. kaoi and XCHT extracts lowered MDA formation as shown in Table 3, it can be concluded that lipid
peroxidation induced by free radicals was reduced.
Membrane stabilization and inhibition of lipid
peroxidation provided by the compounds in XCHT might
play an important hepatoprotective role. Saikosaponins
are triterpenoid compounds found in B. kaoi and have
been reported to possess membrane stabilization capability(29). Administration of saikosaponin-d to rats could
effectively reduce hepatic microsomal lipid peroxidation
induced by CCl4(30). The protective function was also
attributed to the reduction of hepatic drug-metabolizing
enzymes including NADPH-cytochrome C reductase and
cytochrome P-450, which are responsible for the formation of highly toxic free radicals from CCl4. Baicalin, a
compound found in Scutellariae radix, has been reported
to inhibit the formation of MDA in rat liver (31). Baicalein, another bioactive compound found in Scutellariae
radix, also showed antioxidant properties by reducing

FeCl 3 -induced lipid peroxidation(32). Furthermore,
glycyrrhizic acid from Glycyrrhizae radix exerted
both superoxide scavenging activity and inhibited the
FeCl 2/ascorbate-induced lipid peroxidation of rat liver
homogenate (33).
Reactive oxygen species including superoxide free
radical (˙O2), hydroxyl free radical (˙OH), and hydrogen
peroxide (H 2O2) can react with cellular macromolecules
and result in membrane damage and tissue injury (34).
SOD, catalase and GPx are the principal antioxidant
enzymes in vivo; and the activities of these enzymes
represent the in vivo protection capability against oxidative stress (35). SOD protects the biological system by
converting ˙O2 – to hydroperoxide, thus reducing both
direct and indirect cellular damage by free radicals (36).
The hydroperoxide is subsequently transformed to H 2O
and O2 by catalase and the toxicity from free radicals
will be further reduced. While the activities of SOD and
catalase in rat liver were stimulated by CCl4, it is interesting to note that the activities of these two enzymes did
not increase when the B. kaoi and XCHT extracts were
administrated prior to CCl4.
Although oxidative stress from ROS can stimulate
the activities of antioxidant enzymes, the presence of
endogenous or exogenous antioxidant compounds that
are active against ROS would prevent the increase of
such enzymes(37). The increase in CAT and GPx may
compensate the function of hepatocytes on acute peroxidation of CCl4(4). The results in Table 4 suggest that the
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extracts of B. kaoi and XCHT exhibited a protective
function as antioxidants by scavenging ROS.
Being low in catalase content, endothelium and
muscle cells depend on glutathione metabolizing enzyme
system to decompose H 2O2. Coupling with the conversion of glutathione from its reduced form (GSH) to the
oxidized form (GSSG), H 2O2 is converted to H 2O and O2
by GPx(38). Cellular GSH level is restored by GRd through
a NADPH-mediated oxidation-reduction reaction. On
the other hand, endogenous and exogenous electrophilic
compounds are linked to GSH by GST, a multiple function enzyme, to form less toxic glutathione-conjugates(39).
GPx, GRd and GST activities in rat liver were
significantly increased by the administration of CCl4
(Table 5). This increase in enzyme activities was probably a response towards increased CCl 3O2˙ generation in
CCl4 toxicity(4). However, these enzyme activities did not
show any significant increase when the rats were given
the extracts of B. kaoi or XCHT before being given CCl4.
Since GPx, GRd and GST activities did not increase after
the administration of the extracts of B. kaoi or XCHT, it
is assumed that the hepatoprotective functionalities of B.
kaoi or XCHT might not increase the activities of endogenous antioxidative enzymes systems.
The extracts of B. kaoi (500 mg/kg bw) or XCHT could
reduce MDA formation in rat liver, which indicated that the
formation of toxic free radicals and lipid peroxidation were
inhibited by the extracts. Moreover, because the activities
of SOD, catalase, GPx, GRd and GST were compensation
ally increased by the administration of CCl4, it is further
confirmed that the hepatoprotective functionality of B.
kaoi or XCHT extracts was achieved by direct interaction
with toxic free radicals or peroxides and by reversing the
activities of the antioxidant enzymes to the normal levels
rather than by inducing detoxification antioxidant enzymes.
Furthermore, the amount of B. kaoi or XCHT required by
an adult to reach the dosage of 100 mg/kg bw will be in the
range of 350 and 270 mL of B. kaoi or XCHT water extract,
a reasonable quantity from a cup of health drink.
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